Our Company
CRO
CDMO
Stage wise
Custom Solutions
Investors
Our Responsibility
Careers
Resource Hub
Virtual Tour
CONTACT US
‹
Our Responsibility
Digital & AI (DnA)
EHS & Sustainability
Strategic Supply Chain Management
Quality
IP Protection & Data Security
Employee Welfare
Corporate Social Responsibility
Corporate Governance
Careers
Working at Aragen
Career Opportunities
Meet Our People
Caution Notice
Resource Hub
Virtual Tour
CONTACT US
Our Company
About Us
Our Journey
Leadership
Scientific and BD Team
Aragen Advantage
Global Locations
Media & Events
Recognitions
CRO
Small Molecules
Large Molecules/Biologics
Integrated Drug Discovery
Therapeutic areas
Chemistry
Medicinal Chemistry
Synthetic Chemistry
Analytical Chemistry
Specialty Chemistry
Biology
Cell and Protein Sciences
DMPK
Assay Development and Screening
In vivo Pharmacology
BioSafety
Cell Line Development
Antibody Discovery
Molecular Biology
Protein Expression & Purification
Biology
Cell and Protein Sciences
DMPK
Safety Pharmacology
In vivo Pharmacology
BioSafety
Fibrosis
Oncology
Immunology
Infectious Disease
Respiratory Disease
Pain & Inflammation
CardioVascular and Metabolic Diseases
Other Models
Enabling Solutions
Histology and Digital Pathology Services
In Vitro Pharmacology
CDMO
Small Molecules
Large Molecules
Drug Substance
Process Development & Optimization
Process Safety and Risk Management
Technology Transfer
Pilot Lab
IND Enabling Services
Process Validation & Qualification Services
Particle Science and Engineering Services
Process Optimization & Scale Up
Process Engineering
Regulatory Support
Drug Product
Preformulation
Toxicology Formulation
Clinical Formulation
Analytical Development
Method Development & Validation
Stability Studies
Extractable & Leachable Studies
Performance Chemicals
Process Research & Development
Custom Manufacturing
Custom Chemical Synthesis
Drug Substance
Performance Chemicals
Commercial Manufacturing
Process Development & Characterization
Analytical Services
GMP Manufacturing
Stage wise
Early Discovery
CMC
Clinical
Commercialization
Custom Solutions
Advance Modalities
HPAPI
PeptARx
Bioconjugation
CHOMax
TPD
Lipids
Molecular Glue
Oligos
RNA-Based
Investors
Annual Reports and Annual Returns
Corporate Governance
Close Search
Search
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
GET IN TOUCH
Back to Resources
Brochures
Filter by Science
All
All
Analytical
Biologics
Biology
Chemistry
Development
Drug Substance
Formulations BU
Manufacturing
PCET
SAS/Toxicology
Expedite Your Success with Aragen’s Comprehensive IND-Enabling Services
Lipid Chemistry Capabilities
Analytical Solutions
Process Development Services
Resin Recycling Studies
Agro-Chemical Formulation Solutions: Transforming Ideas into Effective Products
Combat Nitrosamine Challenges with Comprehensive Analytical Solutions
Your partner for timely, accurate and high-quality preclinical efficacy studies
Navigating Recombinant Protein Production– Leveraging Aragen’s Multifaceted Expression Systems
Gene to GMP Fully integrated or customized options
Modalities for Mechanistic Exploration in Agrochemical Solutions
Paclitaxel-induced Peripheral Neuropathic Pain Model Developed at Aragen
Comprehensive Services for Immersive Corrosion Testing of Metals and Alloys Across a Wide Spectrum of Test Subjects
Aragen Cell Line Development Solutions for Biologics CHO CLD Platforms
Comprehensive Solutions for Animal Health Biologics
Comprehensive In-Vitro Microbial Kill Rate Studies for screening antimicrobial agents
Genetic and Alternative Toxicity Testing for Compound Screening, Derisking and Selection
Oligonucleotides
Phosphonamidite
Specialized Services in Custom Peptide Synthesis (Solution Phase)
Comprehensive DoE capabilities for Synthesis, Process Development and Manufacturing of Novel Chemical Entities (NCE’s)
Comprehensive GLP regulated Ecotoxicology Services
Comprehensive and Regulated “Developmental and Reproduction Toxicology (DART)” studies
Preclinical Safety Evaluation and Clinical Bioanalysis Services for Vaccines
Intox Safety Assessment
Nonclinical Safety Assessment of New Biological Entities (NBEs)
Process Safety, Dust Explosion Testing Capabilities
Material Science
Aragen Overview
Nonclinical Safety Assessment of New Chemical Entities (NCE)
Aragen protein science solutions: Industry leading upstream and downstream capabilities
Your Partner for Chemocatalysis Solutions
Highly Potent Active Pharmaceutical Ingredients (HPAPIs)
Biocatalysis Solutions
Flow Chemistry
Analytical Solutions Laboratory
Targeted Protein Degradation Solutions
Aragen’s quantitative proteomics sampling capabilities: Accurate and Reproducible Workflows
Pharmacokinetics (PK)/ Pharmacodynamics (PD) and Mechanistics solutions in Ellegaard Göttingen Minipigs
Comprehensive Characterization of Biologics
Aragen’s Preclinical Oncology Capabilities
Preclinical Evaluation of new Antifibrotics in IPF Rodent Models
Pharmacokinetic (PK) solutions in large animals
Formulation Solutions
Discovery Biology Solutions
ADME – DMPK Solutions
Extractables and Leachables Solutions
In Vitro
Pharmacology Solutions
In Vivo
Pharmacology Solutions
Nitrosamine Impurity Detection and Quantification
TOXVIT – Aragen
In Vitro
Toxicology Solutions
ICP-MS
Protein Analytics Solutions
PeptAR
x
– Aragen’s Integrated Peptide Platform
API and Intermediates
Integrated Drug Discovery Solutions
Discovery Chemistry Solutions
Developability and Analytics Solutions
Contract Manufacturing Solutions
Integrated Cell Line Development Solutions
Small Molecule Process R&D and Manufacturing Solutions
Amylin Liver NASH (AMLN)
Learn more about our end-to-end capabilities
+
+